---

Diabetic Neuropathy — A Detailed Overview

Definition

---

Pathophysiology

1. Hyperglycemia-Induced Oxidative Stress

• Chronic hyperglycemia leads to excessive production of reactive oxygen species (ROS)
• ROS cause oxidative damage to neurons and Schwann cells (which form the myelin sheath)
• This creates a bidirectional cycle of cellular signaling dysfunction

2. Polyol Pathway Activation

• Excess glucose is converted to sorbitol by aldose reductase
• Sorbitol accumulates inside nerve cells, causing osmotic damage and depleting myoinositol and NADPH
• This reduces nitric oxide production and impairs nerve conduction

3. Advanced Glycation End Products (AGEs)

• Glucose non-enzymatically binds to proteins, forming AGEs
• AGEs modify myelin proteins, nerve connective tissue, and cross-link structural proteins, impairing nerve function

4. PKC (Protein Kinase C) Activation

• Hyperglycemia activates PKC, which disrupts vascular tone regulation
• Leads to reduced endoneurial blood flow and ischemia of peripheral nerves

5. Free Fatty Acids, Insulin Deficiency, Vasoactive Peptides (Angiotensin II)

• These factors synergize with oxidative stress to amplify neuronal and Schwann cell injury

6. Microvascular Disease

• Thickening of endoneurial capillary basement membrane
• Reduced nerve blood flow → ischemia → axonal degeneration

---

Classification of Diabetic Neuropathy

---

1. Distal Symmetric Polyneuropathy (DSPN)

Symptoms (Sensory-Predominant)

• Numbness and tingling — begins in the toes and feet, ascends proximally ("stocking-glove distribution")
• Burning pain — usually worse at rest and at night
• Hyperesthesia — heightened sensitivity to touch
• Paresthesia/Dysesthesia — abnormal, often unpleasant sensations
• Sharp or shooting pain in the feet/legs
• Up to 50% of patients are asymptomatic, discovered only on examination

Two Subtypes of Pain

Clinical Progression

1. Early: Sensory symptoms (tingling, burning)
2. Middle: Pain subsides but sensory loss persists; loss of protective sensation
3. Late: Motor deficits develop (weakness, wasting of small foot muscles)
4. End-stage: Severe sensory loss → foot ulcers, Charcot arthropathy

Physical Examination Findings

• Loss of sensation to 10-g monofilament (Semmes-Weinstein)
• Loss of vibration sense (128 Hz tuning fork)
• Loss of ankle deep-tendon reflexes
• Abnormal position sense (proprioception)
• Small muscle wasting in the feet

---

2. Diabetic Autonomic Neuropathy (DAN)

Cardiovascular

• Resting tachycardia (HR >100 bpm)
• Orthostatic hypotension (BP drop >20 mmHg systolic on standing)
• Reduced heart rate variability
• Silent myocardial ischemia (no chest pain due to cardiac denervation)
• Increased risk of sudden cardiac death

Gastrointestinal

• Gastroparesis diabeticorum — delayed gastric emptying; nausea, early satiety, vomiting, bloating
• Diabetic enteropathy — nocturnal diarrhea (alternating with constipation)
• Esophageal dysmotility — dysphagia

Genitourinary

• Neurogenic bladder — incomplete emptying, overflow incontinence, recurrent UTIs
• Erectile dysfunction — present in 30–75% of diabetic males
• Retrograde ejaculation
• Female sexual dysfunction — decreased vaginal lubrication

Sudomotor (Sweat Gland)

• Anhidrosis (decreased sweating) distally → compensatory hyperhidrosis proximally
• Dry, cracked skin in feet → entry point for infections

Pupillary

• Reduced pupillary dilation in dark
• Impaired adaptation to darkness

---

3. Focal and Multifocal Neuropathies

Cranial Neuropathy

• Most commonly affects CN III (oculomotor nerve)
• Presents with painful ptosis and ophthalmoplegia, with pupil sparing (distinguishes from posterior communicating artery aneurysm)
• Also CN IV, VI, VII may be affected

Mononeuropathy (Entrapment)

• Diabetics are predisposed to nerve compression:
  • Carpal tunnel syndrome (median nerve) — most common
  • Ulnar neuropathy
  • Peroneal nerve palsy → foot drop
  • Lateral femoral cutaneous nerve → meralgia paresthetica

Diabetic Radiculoplexopathy (Diabetic Amyotrophy / Bruns-Garland Syndrome)

• Affects older T2DM patients
• Sudden onset severe proximal leg pain, followed by weakness and wasting (quadriceps most affected)
• Unilateral or asymmetric
• Mechanism: microvasculitis of lumbosacral plexus/nerve roots
• Gradual recovery over months to years

---

Diagnosis

Clinical Assessment Tools

Scoring Systems

• Michigan Neuropathy Screening Instrument (MNSI)
• Toronto Clinical Neuropathy Score
• Neuropathy Symptom Score (NSS) and Neuropathy Disability Score (NDS)

Electrophysiological Testing

• Nerve Conduction Studies (NCS) — gold standard for large fiber neuropathy; detects reduced amplitudes and slowed conduction velocity
• Electromyography (EMG) — detects denervation in muscles

Specialized Tests

• Quantitative Sensory Testing (QST) — thresholds for vibration, temperature (small and large fiber)
• Skin punch biopsy — measures intraepidermal nerve fiber density (IENFD); best test for small fiber neuropathy
• Quantitative Sudomotor Axon Reflex Test (QSART) — for autonomic sudomotor function
• Tilt table test, heart rate variability — for cardiovascular autonomic neuropathy

Screening Recommendations (ADA)

• All T2DM patients: screen at diagnosis, then annually
• T1DM patients: screen 5 years after diagnosis, then annually

---

Treatment and Management

A. Disease-Modifying (Addressing the Cause)

B. Symptomatic Pharmacological Treatment (Painful DSPN)

• Tapentadol (centrally acting opioid/NRI) — FDA-approved for painful DPN
• Opioids — generally avoided as long-term therapy due to dependence risk

C. Non-Pharmacological

• Physical therapy — balance training, strengthening
• Transcutaneous Electrical Nerve Stimulation (TENS)
• Spinal cord stimulation — for refractory cases
• Cognitive behavioral therapy (CBT) — for chronic pain coping

D. Management of Autonomic Neuropathy

---

Complications

---

Prognosis

• DSPN is largely irreversible once established; treatment is aimed at slowing progression and controlling symptoms
• Acute painful neuropathy (treatment-induced) generally resolves within 12 months
• Focal neuropathies (mononeuropathy, amyotrophy) often partially or fully recover spontaneously
• Autonomic neuropathy significantly worsens prognosis — cardiovascular autonomic neuropathy increases mortality risk by 2–5 fold
• Early detection and strict glycemic control remain the most effective preventive strategies

---

Key Takeaways

1. Diabetic neuropathy is the most common complication of diabetes
2. DSPN is the most common subtype — stocking-glove sensory loss, worse at night
3. Pathogenesis involves oxidative stress, polyol pathway, AGEs, and microvascular ischemia
4. 50% of patients are asymptomatic — routine annual screening is essential
5. Duloxetine and pregabalin are first-line FDA-approved treatments for painful DPN
6. Autonomic neuropathy can affect every organ system and increases mortality
7. Foot care is critical — diabetic neuropathy is the leading cause of preventable lower limb amputation

---

Thoracic Outlet Syndrome (TOS) — Detailed Overview

Definition

---

Anatomy of the Thoracic Outlet

1. Interscalene Triangle

• Boundaries: Anterior scalene muscle (anteriorly), middle scalene muscle (posteriorly), first rib (inferiorly)
• Contents: Brachial plexus and subclavian artery pass through here
• Most common site of neurogenic and arterial TOS

2. Costoclavicular Space

• Boundaries: Clavicle (superiorly), first rib (inferiorly), superior border of scapula (posteriorly)
• Contents: Subclavian vein, artery, and brachial plexus
• Compressed during shoulder depression or retraction

3. Subcoracoid (Retropectoralis Minor) Space

• Boundaries: Pectoralis minor tendon (anteriorly), coracoid process (superiorly), ribs (posteriorly)
• Compression occurs when the arm is raised overhead

---

Etiology and Risk Factors

Structural/Anatomical Causes

Acquired/Positional Causes

• Poor posture — forward head, rounded shoulders narrow the outlet
• Repetitive overhead activities — swimmers, baseball pitchers, painters, electricians
• Rapid weight gain — fat deposition narrows spaces
• Neck/shoulder muscle hypertrophy — bodybuilders
• Trauma — whiplash injury, clavicle or first rib fractures
• Effort thrombosis — repetitive upper limb exertion causing venous TOS (Paget-Schroetter syndrome)

Predisposing Demographics

• More common in women (3:1 female-to-male ratio for neurogenic TOS)
• Peak age: 20–50 years
• Common in athletes and manual workers

---

Classification

---

1. Neurogenic TOS (nTOS) — Most Common (~95%)

Subtypes

Pathophysiology

• Compression of the lower trunk of the brachial plexus (C8–T1 nerve roots) by an anomalous fibrocartilaginous band
• The elongated C7 transverse process anchors this band, creating a tether that distorts and compresses the lower trunk
• Results in denervation of intrinsic hand muscles (ulnar and median innervated)

Clinical Features — True Neurogenic TOS

• Pain: Mild or absent (distinguishes it from disputed TOS)
• Weakness and wasting: Intrinsic muscles of the hand — particularly thenar (median) and hypothenar (ulnar) muscles
• Sensory loss: Palmar aspect of the 5th digit and medial forearm (T1 distribution)
• Insidious progression: Gradual muscle atrophy over months to years
• The classic presentation: Gilliatt-Sumner hand — wasting of thenar eminence > hypothenar

Clinical Features — Disputed Neurogenic TOS

• Shoulder and arm pain — diffuse, aching
• Paresthesias — tingling in arm and hand, often in ulnar distribution
• Neck pain — radiating to occipital region
• Headache — especially occipital
• Weakness — subjective, without objective muscle atrophy
• Symptoms reproduced or worsened by overhead activities, carrying bags, certain head positions

---

2. Venous TOS (vTOS) — Paget-Schroetter Syndrome (~3–4%)

Pathophysiology

• Compression of the subclavian and axillary vein in the costoclavicular space
• Repetitive arm activity → microtrauma → perivenous fibrosis → acute thrombosis
• Often precipitated by an episode of unusual or strenuous arm effort ("effort thrombosis")

Clinical Features

• Sudden onset of arm swelling, heaviness, and cyanosis
• Pitting edema of the entire upper extremity
• Dilated superficial collateral veins visible over shoulder and chest wall
• Arm pain and fatigue with use
• Usually affects the dominant arm
• Risk of pulmonary embolism (less common than DVT of lower extremity but documented)
• Common in young athletes — swimmers, rowers, baseball pitchers, weightlifters

---

3. Arterial TOS (aTOS) — Rarest (~1–2%)

Pathophysiology

• Compression of the subclavian artery between the cervical rib (or anomalous first rib) and the clavicle
• Chronic compression → post-stenotic dilatation → aneurysm formation → thrombus → distal embolization

Clinical Features

• Arm claudication — pain with upper limb exertion, relieved by rest
• Raynaud's phenomenon — episodic color changes in fingers (white → blue → red)
• Digital ischemia — cold, pale, painful fingers
• Ischemic tissue loss — ulceration of fingertips
• Gangrene in severe/advanced cases
• Pulsatile mass in the supraclavicular fossa (if subclavian artery aneurysm present)
• Absent or diminished radial pulse with provocative maneuvers

---

Clinical Provocative Tests

Important: Pulse obliteration alone on these tests is not diagnostic — it occurs in up to 50% of asymptomatic individuals. Clinical correlation is mandatory.

---

Diagnosis

History and Physical Examination

• Detailed occupational and activity history
• Neurological examination: muscle strength, sensory testing, deep tendon reflexes
• Vascular examination: pulse assessment, blood pressure in both arms, capillary refill

Imaging

Electrodiagnostic Studies

• Nerve Conduction Studies (NCS): In true neurogenic TOS — reduced amplitude of medial antebrachial cutaneous sensory nerve; reduced ulnar sensory/motor amplitudes
• EMG: Denervation in C8–T1 muscles (first dorsal interosseous, abductor pollicis brevis)
• NCS may be normal in disputed neurogenic TOS

Vascular Studies

• Venography: Gold standard for diagnosing subclavian vein thrombosis in vTOS
• Arteriography: For evaluation of arterial stenosis/aneurysm in aTOS

---

Differential Diagnosis

---

Treatment

Conservative Management (First-line for Neurogenic TOS)

• Postural correction — strengthen neck and shoulder stabilizers, correct forward head posture
• Scalene and pectoralis minor stretching — reduce compression
• Shoulder girdle strengthening — trapezius, rhomboids, serratus anterior
• Breathing exercises — avoid accessory muscle overuse
• Duration: 6–12 weeks minimum; success rate ~60–70% in disputed nTOS

• NSAIDs — for inflammatory/myofascial pain component
• Muscle relaxants — cyclobenzaprine, baclofen (short-term)
• Neuropathic pain agents — gabapentin, pregabalin (for neurogenic pain)
• Anticoagulation — for venous TOS with thrombosis (heparin → warfarin or DOAC)
• Thrombolytics — catheter-directed thrombolysis in acute vTOS

• Injected into anterior scalene muscle
• Temporarily relieves scalene muscle compression
• Useful diagnostically and therapeutically; effects last 3–6 months

Surgical Management

1. True neurogenic TOS — surgical resection of the anomalous band is definitive treatment
2. Failed conservative therapy (6–12 months) in neurogenic TOS
3. All arterial TOS — needs vascular reconstruction
4. Venous TOS (after thrombolysis) — to prevent recurrent thrombosis

• Resection of anomalous fibrocartilaginous band — for true nTOS (halts progression)
• Scalenectomy / scalenotomy — release of anterior (and sometimes middle) scalene
• First rib resection — decompresses costoclavicular space
• Cervical rib excision — when present and causative
• Vascular reconstruction — bypass or patch angioplasty for subclavian artery aneurysm/stenosis in aTOS
• Catheter-directed thrombolysis + first rib resection — staged management of Paget-Schroetter syndrome

---

Prognosis

---

Complications

---

Key Takeaways

1. TOS = compression of neurovascular bundle (brachial plexus, subclavian artery/vein) at the thoracic outlet
2. Neurogenic TOS (95%) is the most common — true (objective) vs. disputed (no objective findings)
3. True neurogenic TOS is caused by an anomalous fibrocartilaginous band from the C7 transverse process to the first rib
4. Cervical rib is the most recognizable anatomical risk factor; present in <1% of population
5. Provocative tests (Roos, Adson, Wright) support diagnosis but pulse obliteration alone is not diagnostic
6. Physical therapy is first-line for neurogenic TOS; surgery for true nTOS, arterial TOS, and refractory cases
7. True neurogenic TOS: surgery stops progression but does not reverse muscle wasting
8. Venous TOS (Paget-Schroetter) = effort thrombosis in young athletes — treat with thrombolysis + rib resection
9. Arterial TOS is rare but most dangerous — risk of gangrene if untreated

---

Botulism — Detailed Overview

Definition

---

The Causative Organism

Clostridium botulinum

Related Species (Rare Causes)

• C. baratii — produces type F toxin; causes infant botulism
• C. butyricum — produces type E toxin; reported in Italy and India

---

The Toxin

Potency

• Estimated lethal oral dose (70 kg man): ~70 µg
• Estimated lethal inhaled dose (70 kg man): ~0.80–0.90 µg
• Classified as a Category A bioterrorism agent by the CDC

Toxin Structure

• A 150 kDa di-chain protein consisting of:
  • Heavy chain (100 kDa) — binds to presynaptic nerve terminal receptors (e.g., SV2C for BoNT/A)
  • Light chain (50 kDa) — zinc-dependent endopeptidase (the toxic component)

Toxin Serotypes and Clinical Relevance

---

Pathophysiology

Conditions Required for Toxin Production

• Anaerobic environment
• Low acidity (pH > 4.5)
• Low salt and sugar content
• Temperature: 3°C–37°C (37°F–99°F)

Mechanism of Action — Step by Step

• The heavy chain of the toxin binds with high affinity to specific receptors on the presynaptic membrane of peripheral cholinergic nerve terminals (neuromuscular junctions, autonomic ganglia, parasympathetic nerve endings)
• BoNT/A and E bind SV2 (synaptic vesicle glycoprotein 2)
• BoNT/B, D, F, G bind synaptotagmin

• Toxin-receptor complex is endocytosed into an acidified endosome
• Acidic pH triggers conformational change in the heavy chain, forming a pore in the endosomal membrane

• The light chain is translocated through the pore into the cytoplasm

• The light chain acts as a zinc-dependent endopeptidase
• It cleaves SNARE proteins — the molecular machinery required for acetylcholine (ACh) vesicle docking and fusion:

• SNARE cleavage prevents ACh vesicle fusion with the presynaptic membrane
• Acetylcholine release is blocked at the neuromuscular junction
• Result: flaccid paralysis (lower motor neuron pattern — weakness without spasticity)
• Also affects autonomic cholinergic synapses → autonomic dysfunction

---

Types / Forms of Botulism

Overview Table

---

1. Foodborne Botulism

Epidemiology

• Most recognized form in outbreaks
• In the USA: ~15–25 cases/year
• Type A and B from home-canned vegetables, meats
• Type E from fermented fish (Alaska Natives) and smoked fish

Common Food Sources

Mechanism

• Preformed toxin is ingested in contaminated food
• Toxin is absorbed through the small intestine
• Enters systemic circulation → targets peripheral cholinergic nerve terminals

Clinical Course

• Incubation: 6 hours to 10 days (typically 12–36 hours)
• Shorter incubation = larger toxin dose = more severe illness
• Initial GI symptoms: nausea, vomiting, abdominal cramps, diarrhea
• Followed by descending flaccid paralysis (see Clinical Features below)

---

2. Infant Botulism

Epidemiology

• Most common form in the USA (~65–85% of all cases)
• ~100–150 cases/year in the USA
• Ages: 3 weeks to 12 months (peak: 2–4 months)
• Spores ingested from:
  • Honey (most famous source — should NEVER be given to infants < 1 year)
  • Soil (tracked in on shoes, clothing)
  • Corn syrup (historical association)
  • Environmental dust

Mechanism

• Ingested spores germinate in the intestinal lumen (infant gut lacks competing flora and protective acid)
• Toxin produced in situ → absorbed into bloodstream

Clinical Features

• "Floppy baby" syndrome:
  • Constipation (often first sign — poor colonic motility)
  • Weak cry
  • Poor feeding, weak suck
  • Hypotonia ("rag doll" appearance)
  • Ptosis, expressionless face
  • Loss of head control
  • Decreased deep tendon reflexes
• Progression to respiratory failure if untreated
• Sudden infant death (SIDS) has been linked to undiagnosed infant botulism

Treatment

• BabyBIG (Botulism Immune Globulin Intravenous — Human) — FDA-approved specifically for infant botulism
• Antitoxin (equine) is NOT used in infants
• Supportive care; hospitalization

---

3. Wound Botulism

Epidemiology

• Rising incidence due to injection drug use (particularly black tar heroin)
• Also: traumatic wounds, compound fractures, crush injuries
• Type A predominates
• Incubation: 4–14 days from wound contamination

Mechanism

• Spores introduced into wound → anaerobic environment → germination → in vivo toxin production → toxin enters bloodstream

Key Difference from Foodborne

• No GI symptoms (toxin not ingested)
• Wound may appear deceptively benign or even well-healed
• Fever may be present if co-infected

High-Risk Groups

• Black tar heroin users (subcutaneous/intramuscular injection "skin popping")
• Patients with sinusitis from intranasal cocaine use (rare)

---

4. Adult Intestinal Toxemia (Adult Infant Botulism)

• Very rare; mirrors infant botulism in mechanism
• Occurs in adults with altered GI anatomy (bowel surgery, inflammatory bowel disease) or immunosuppression
• Spores colonize the adult intestine and produce toxin in situ

---

5. Iatrogenic Botulism

• Results from therapeutic or cosmetic use of botulinum toxin injections (Botox, Dysport, Xeomin)
• Usually from:
  • Excessive doses
  • Unintended spread to adjacent muscles
  • Treatment of conditions like spasticity, hyperhidrosis, dystonia, cosmetic wrinkle reduction
• Symptoms: localized or regional weakness beyond intended area, dysphagia, diplopia

---

Clinical Features — The Classic Presentation

The "Four D's" + Descending Paralysis

• Diplopia (double vision)
• Dysarthria (slurred speech)
• Dysphonia (hoarse voice)
• Dysphagia (difficulty swallowing)
• Followed by descending symmetric flaccid paralysis

Cranial Nerve Involvement (Earliest Signs)

Autonomic Features

• Dry mouth (xerostomia) — from blocked salivary gland cholinergic innervation
• Mydriasis (dilated, poorly reactive pupils) — key finding
• Constipation — reduced GI motility
• Urinary retention
• Orthostatic hypotension
• Anhidrosis (decreased sweating)

Motor Involvement — Descending Pattern

1. Cranial nerve muscles (face, eyes, throat)
2. Neck muscles
3. Upper limbs
4. Respiratory muscles (diaphragm, intercostals)
5. Lower limbs

Respiratory Failure

• The primary cause of death in botulism
• Results from weakness of the diaphragm and accessory respiratory muscles
• Requires mechanical ventilation — may last weeks to months
• Patients must be monitored with serial vital capacity (VC) measurements

Key Features That DISTINGUISH Botulism from Other Disorders

---

Diagnosis

Clinical Diagnosis — High Suspicion Required

"Diagnosis of botulism depends on high clinical suspicion and a thorough neurologic examination. The timeliness of diagnosis is crucial to successful treatment."

Laboratory Confirmation

Electrodiagnostic Studies (EMG/NCS)

The EMG pattern of botulism resembles Lambert-Eaton Myasthenic Syndrome (LEMS) — both show facilitation at high-frequency stimulation — unlike myasthenia gravis, which shows decremental response.

Lumbar Puncture

• Normal CSF — helps exclude Guillain-Barré syndrome (which shows elevated CSF protein)

---

Differential Diagnosis

---

Treatment

1. Antitoxin (Cornerstone of Specific Therapy)

• In the USA, HBAT is available free of charge, 24/7 through the CDC Strategic National Stockpile
• Anaphylaxis risk with equine antitoxin — skin test before administration

2. Supportive Care (Critical)

• Mechanical ventilation — primary intervention for respiratory failure; may be required for weeks to months
• Close monitoring: serial forced vital capacity (FVC), negative inspiratory force (NIF)
• Intubate early if FVC < 30% predicted or declining
• Nasogastric/PEG tube feeding — for dysphagia and nutritional support
• Urinary catheterization — for urinary retention
• Bowel regimen — for constipation
• DVT prophylaxis — for immobile patients
• ICU care — monitoring for complications

3. Wound Botulism — Additional Management

• Surgical debridement of the wound to eliminate ongoing toxin production
• Antibiotics: Penicillin G or metronidazole
  • Aminoglycosides are CONTRAINDICATED — they can worsen neuromuscular blockade
• Antitoxin administered before debridement (to prevent bacteremia-related toxin release)

4. Infant Botulism

• BabyBIG — given as a single IV infusion; reduces hospital stay by ~3 weeks
• Breast milk encouraged (provides immunological benefit)
• Antibiotics NOT routinely recommended — may lyse intestinal C. botulinum, causing sudden toxin release

5. No Role For

• Cathartics/enemas in foodborne botulism — may accelerate toxin absorption
• Guanidine hydrochloride — historically tried; not effective
• Edrophonium (Tensilon test) — negative in botulism (unlike MG)

---

Public Health and Reporting

• Botulism is a notifiable disease — immediately reportable to local/state health departments
• Foodborne botulism cases trigger food source investigation to prevent outbreak spread
• CDC and state health departments provide 24/7 emergency consultation and antitoxin delivery
• All suspected cases must be reported even before laboratory confirmation

---

Bioterrorism Potential

• Botulinum toxin is classified as a CDC Category A bioterrorism agent — highest priority
• Potential delivery: aerosolization or food/water contamination
• Inhalational botulism:
  • Does not naturally occur
  • Incubation: 12–36 hours after aerosol exposure
  • Clinical picture identical to foodborne botulism
  • Would present as a cluster of unexplained descending paralysis cases
• Strategic national stockpile of antitoxin maintained for mass casualty events

---

Prognosis

Mechanism of Recovery

• Recovery does not occur by reversal of SNARE cleavage
• The nerve terminal sprouts new axonal branches with new SNARE proteins
• Original damaged terminal eventually recovers as well
• Process takes weeks to months

---

Prevention

---

Key Takeaways

1. Botulinum toxin is the most potent biological toxin known — blocks ACh release at NMJ by cleaving SNARE proteins
2. Results in descending flaccid paralysis + autonomic dysfunction (dry mouth, dilated pupils, constipation)
3. Infant botulism is the most common form in the USA — never give honey to infants < 1 year
4. Foodborne botulism is from preformed toxin in improperly preserved food; wound botulism increasingly from IV drug use
5. Key clinical clues: alert patient + descending paralysis + dilated pupils + dry mouth + NO sensory loss + NO fever
6. Antitoxin (HBAT) must be given as early as possible — it cannot reverse internalized toxin
7. Respiratory failure is the primary cause of death — proactive mechanical ventilation is life-saving
8. Aminoglycosides are contraindicated in wound botulism
9. Recovery occurs through new nerve terminal sprouting — takes weeks to months
10. All cases must be immediately reported to public health authorities

---

Comprehensive Neurology & Neurosurgery Review

---

1. Cranial Nerve V (Trigeminal Nerve) Examination

A. Sensory Examination

• Light touch — use cotton wisp; ask patient to indicate when and where felt
• Pain/pinprick — use a pin; compare sides
• Temperature — warm and cold test tubes applied to face
• Compare both sides symmetrically; note any areas of reduced/absent sensation

B. Motor Examination (V3 — Mandibular Branch Only)

• Muscles: Masseter, temporalis, pterygoids (medial and lateral)
• Inspection: Look for wasting of masseter and temporalis
• Jaw opening: Ask patient to open the mouth — jaw deviates to the side of the lesion (weak pterygoid)
• Jaw closure: Ask patient to clench teeth; palpate masseter and temporalis for bulk and strength
• Jaw jerk reflex: Tap the chin with mouth slightly open — brisk jaw jerk suggests upper motor neuron lesion above the pons

C. Corneal Reflex (Afferent: V1; Efferent: VII)

• Gently touch the cornea (not conjunctiva) with a fine wisp of cotton from the side
• Normal: Bilateral blink (direct + consensual)
• Absent direct, present consensual: V1 lesion on that side
• Absent consensual, present direct: CN VII lesion on that side

D. Summary of Abnormalities

---

2. CN VII (Facial Nerve) Assessment

A. Motor Assessment

• Observe for facial asymmetry, drooping of one side, loss of nasolabial fold, widened palpebral fissure

B. UMN vs. LMN Facial Palsy

C. Taste Testing

• Apply sweet, salty, sour, or bitter solutions to the anterior 2/3 of the tongue on one side
• Patient identifies taste without retracting tongue
• Loss of taste (ageusia) on anterior 2/3 suggests lesion proximal to chorda tympani

D. Other Tests

• Schirmer's test: Reduced lacrimation on affected side (lesion above greater petrosal nerve)
• Stapedial reflex: Absent in lesions above the nerve to stapedius → hyperacusis
• Audiometry: To detect associated CN VIII involvement

---

3. Tests for Visual Acuity and Visual Field

A. Visual Acuity

• Patient stands 6 metres from chart (or 20 feet)
• Tested one eye at a time (cover the other)
• Patient reads smallest line possible
• Recorded as: 6/6 (normal) = at 6m, sees what normal eye sees at 6m
• 6/60 = at 6m, sees only what normal eye sees at 60m (severe reduction)
• If patient wears glasses, test with glasses on ("best corrected visual acuity")

• Jaeger chart — held at 33 cm; tests near vision (J1 = normal)

• If acuity improves with pinhole → refractive error (not neurological/retinal)
• If no improvement → suggests organic pathology (optic nerve, retina, media opacity)

B. Visual Field Testing

• Examiner sits 1 metre facing patient, both at same eye level
• Cover one eye (examiner covers opposite eye — mirror image)
• Patient fixes gaze on examiner's nose
• Examiner brings a moving finger/target from periphery into the field
• Test all four quadrants (upper/lower, nasal/temporal)
• Patient indicates when target is first seen

• Goldmann perimetry — manual kinetic perimetry; maps isopters
• Humphrey visual field analyser — automated static perimetry; most commonly used clinically
• Amsler grid — central 10° field; detects macular/central scotomas

C. Common Visual Field Defects and Their Localisation

---

4. Glasgow Coma Scale (GCS)

Scoring Table

Interpretation

• Minimum score: 3 (not 0)
• Coma: GCS ≤ 8 with no eye opening, no verbal response, no motor command following

---

5. Three Higher Mental Functions

1. Orientation

• Time: Day, date, month, year, season
• Place: Where the patient is (hospital, city, country)
• Person: Awareness of own identity and recognition of familiar people
• Tests: "What is today's date? What place are we in?"
• Disorientation (especially to time first) is an early sign of cognitive impairment

2. Memory

• Immediate memory (registration): Repeat 3 words immediately after saying them
• Short-term (recent) memory: Recall those 3 words after 3–5 minutes
• Long-term (remote) memory: Ask about past events (date of birth, historical events)
• Tests: Digit span, name-and-address recall
• Early Alzheimer's: Short-term memory affected first

3. Attention and Concentration

• Serial 7s: Count backwards from 100 in steps of 7 (100, 93, 86...)
• Spell "WORLD" backwards: D-L-R-O-W
• Digit span: Repeat strings of numbers forwards (normal ≥ 6) and backwards (normal ≥ 4)
• Impaired in delirium, frontal lobe lesions, metabolic encephalopathy

Other higher mental functions include: language (aphasia assessment), praxis (apraxia), gnosis (agnosia), executive function, calculation, and visuospatial ability.

---

6. Three Uses of Lumbar Puncture

1. Diagnosis of meningitis and encephalitis — CSF analysis for cells, glucose, protein, organisms (bacterial, viral, fungal); India ink stain for cryptococcal meningitis; PCR for HSV encephalitis
2. Diagnosis of subarachnoid haemorrhage (SAH) — when CT head is normal but clinical suspicion high; xanthochromia (yellow discolouration of CSF) from haemoglobin breakdown confirms SAH
3. Measurement of intracranial pressure / therapeutic drainage — in idiopathic intracranial hypertension (pseudotumour cerebri); also diagnostic in normal pressure hydrocephalus (gait improvement after LP)

---

7. Three Complications of Lumbar Puncture

1. Post-LP headache (post-dural puncture headache) — most common complication; positional headache (worse upright, relieved lying flat); due to CSF leak through dural puncture; treated with bed rest, analgesia, IV fluids, or blood patch
2. Herniation (transtentorial or tonsillar) — most dangerous complication; occurs if LP performed in the presence of raised ICP with space-occupying lesion; brainstem compressed downward; prevented by CT head before LP if any signs of raised ICP
3. Spinal haematoma or infection — epidural/subdural haematoma (especially in coagulopathy); or introduced infection causing meningitis/epidural abscess

---

8. Internuclear Ophthalmoplegia (INO)

Anatomy

Clinical Features

• Ipsilateral eye (side of MLF lesion): Fails to adduct (turn inward) — the medial rectus appears paralysed
• Contralateral eye (side of gaze): Abducts normally but shows nystagmus
• Convergence: Usually preserved (distinguishes from CN III palsy)

Causes

• Bilateral INO in young patients → Multiple sclerosis (most common)
• Unilateral INO in older patients → Brainstem infarction (pontine stroke)
• Also: brainstem tumour, Wernicke's encephalopathy

---

9. Three Causes of Ptosis

1. CN III (Oculomotor) Palsy — complete ptosis; associated with "down and out" eye position, dilated pupil (pupil-involving); causes: posterior communicating artery aneurysm, uncal herniation, diabetic mononeuropathy (pupil-sparing)
2. Horner's Syndrome — partial ptosis + miosis + anhidrosis (partial ptosis as Müller's muscle is sympathetically innervated); causes: Pancoast tumour, carotid artery dissection, brainstem stroke
3. Myasthenia Gravis — fatigable ptosis that worsens with sustained upgaze; bilateral but often asymmetric; associated with fatigable diplopia; improves with rest or ice pack test

---

10. Three Causes of Papilloedema

1. Space-occupying lesion (SOL) — brain tumour (primary or metastatic), abscess, or haematoma raises ICP by mass effect; most common cause
2. Idiopathic Intracranial Hypertension (Pseudotumour Cerebri) — raised ICP with no structural lesion; common in obese young women; associated with vitamin A toxicity, tetracyclines, OCP use
3. Venous sinus thrombosis (Cerebral venous thrombosis) — occlusion of dural venous sinuses impairs CSF reabsorption → raised ICP; associated with hypercoagulable states, OCP, dehydration, pregnancy

---

11. Three Differences: UMN vs. LMN Lesion

---

12. Three Causes of Bell's Palsy

1. Herpes Simplex Virus (HSV-1) reactivation — most accepted cause of "idiopathic" Bell's palsy; viral reactivation in the geniculate ganglion causes inflammation and oedema of the facial nerve in its bony canal
2. Ramsay Hunt Syndrome — Herpes Zoster (VZV) reactivation in the geniculate ganglion; presents with facial palsy + painful vesicles in the ear (auricle/external auditory canal) + sensorineural hearing loss
3. Lyme disease (Borrelia burgdorferi) — can cause unilateral or bilateral facial nerve palsy; should be considered in endemic areas with tick exposure history

---

13. Trigeminal Neuralgia

Clinical Features

• Pain quality: Sudden, lancinating, electric shock-like; extremely severe
• Duration: Seconds to 2 minutes per episode
• Distribution: Usually V2 (maxillary) or V3 (mandibular), rarely V1 alone
• Unilateral: Right > left; bilateral in <5%
• Trigger zones: Light touch to specific areas — chewing, speaking, brushing teeth, cold wind, washing face
• Pain-free intervals between attacks
• No neurological deficit in classical form
• Age: Usually > 50 years; women > men

Classification

Management

• First-line drug: Carbamazepine (most effective; sodium channel blocker)
• Second-line: Oxcarbazepine, lamotrigine, baclofen, gabapentin
• Surgical: Microvascular decompression (MVD) — separates offending vessel from trigeminal root; most durable cure; Gamma Knife radiosurgery; percutaneous rhizotomy

---

14. Dysphagia

Types

Neurological Causes

• Stroke (corticobulbar or brainstem)
• Bulbar/pseudobulbar palsy
• Motor neuron disease
• Myasthenia gravis
• Parkinson's disease
• Guillain-Barré syndrome

---

15. Three Symptoms of Ischaemic Stroke

1. Sudden unilateral weakness or paralysis — contralateral hemiplegia/hemiparesis (face, arm, leg); most common and dramatic feature due to involvement of motor pathways
2. Sudden speech disturbance — aphasia (dominant hemisphere lesion: Broca's = expressive, Wernicke's = receptive) or dysarthria (slurred speech from motor pathway involvement)
3. Sudden sensory loss — contralateral hemisensory loss (numbness, tingling) from thalamic or parietal cortex involvement; often accompanies motor deficit

---

16. Autonomic Dysreflexia

Pathophysiology

• A noxious stimulus below the level of injury (e.g., full bladder, bowel impaction) triggers a massive sympathetic reflex
• Ascending inhibitory signals from higher centres cannot pass the lesion (blocked at T6 or above)
• Result: severe hypertension below the level of lesion
• Baroreceptors detect hypertension → parasympathetic response (bradycardia, vasodilation, flushing) above the lesion — but cannot control the hypertension below

Clinical Features

Common Triggers

• Bladder — urinary retention, kinked catheter, UTI (most common)
• Bowel — constipation, faecal impaction, rectal examination
• Skin — pressure sores, tight clothing, ingrown toenail, wound
• Uterine contractions (labour in pregnant paraplegics)

Management

1. Sit patient upright (orthostatic drop in BP)
2. Identify and remove the trigger (empty bladder, relieve bowel impaction)
3. Antihypertensives if BP remains high: sublingual nifedipine or GTN, IV labetalol
4. Never leave patient unattended

---

17. Risk Factors of Stroke

Non-Modifiable

• Age (risk doubles each decade after 55)
• Male sex
• Race/ethnicity (African-American > Caucasian)
• Family history / genetic predisposition
• Previous stroke or TIA

Modifiable (Major)

• Hypertension — single most important modifiable risk factor
• Atrial fibrillation — 5x risk of embolic stroke
• Diabetes mellitus
• Dyslipidaemia (high LDL, low HDL)
• Cigarette smoking
• Carotid artery stenosis

Other Modifiable

• Obesity and physical inactivity
• Alcohol excess
• Oral contraceptive pill (especially with migraine with aura)
• Obstructive sleep apnoea
• Hypercoagulable states (antiphospholipid syndrome, Factor V Leiden)
• Valvular heart disease, cardiomyopathy

---

18. Three Causes of Stroke in Young Population (< 45 years)

1. Cardiac embolism — patent foramen ovale (PFO) with paradoxical embolism, atrial septal defect, infective endocarditis, cardiomyopathy; most common identifiable cause in young adults
2. Cervical artery dissection — carotid or vertebral artery dissection following neck trauma, chiropractic manipulation, or spontaneously; blood clots in false lumen and embolises; presents with neck pain, Horner's syndrome, then stroke
3. Hypercoagulable / thrombophilic states — antiphospholipid syndrome, protein C/S deficiency, Factor V Leiden mutation, sickle cell disease; cause arterial or venous thrombosis

---

19. Define Cerebrovascular Accident (CVA)

• Ischaemic stroke (~85%): Occlusion of a cerebral artery (thrombotic or embolic) → infarction of brain tissue
• Haemorrhagic stroke (~15%): Rupture of a blood vessel → intracerebral haemorrhage or subarachnoid haemorrhage

TIA (Transient Ischaemic Attack): Same mechanism but symptoms resolve within 24 hours (typically < 1 hour); no permanent infarction on imaging.

---

20. Three Complications of Head Injury

1. Intracranial haematoma — extradural (arterial — middle meningeal artery), subdural (venous — bridging veins), or intracerebral; presents with lucid interval then deterioration (EDH), or gradual onset (SDH); requires urgent surgical evacuation
2. Post-traumatic epilepsy — early (<1 week) or late (>1 week); cortical scarring acts as epileptic focus; risk higher with penetrating injury, depressed skull fracture, intracerebral haematoma
3. Post-traumatic cognitive and personality changes / diffuse axonal injury — widespread shearing of axons at grey-white matter junctions; leads to persistent vegetative state, cognitive impairment, behavioural changes, depression

---

21. Postural (Orthostatic) Hypotension

Mechanism

Causes

• Neurogenic: Autonomic neuropathy (diabetes), Parkinson's disease, multiple system atrophy, pure autonomic failure
• Hypovolaemia: Dehydration, blood loss, Addison's disease
• Drugs: Antihypertensives, diuretics, alpha-blockers, tricyclic antidepressants, levodopa

Symptoms

• Dizziness, lightheadedness, pre-syncope/syncope on standing
• Visual blurring, weakness, falls in elderly

---

22. Three Causes of Dementia

1. Alzheimer's Disease — most common (~60–70%); progressive loss of short-term memory first; amyloid plaques and neurofibrillary tangles; cholinergic deficit; gradual global cognitive decline
2. Vascular Dementia — second most common; stepwise deterioration; history of stroke/TIAs; risk factors overlap with cardiovascular disease; subcortical ischaemic changes on MRI
3. Lewy Body Dementia (DLB) — fluctuating cognition, visual hallucinations, Parkinsonism (rigidity, bradykinesia); REM sleep behaviour disorder; extreme sensitivity to antipsychotics

---

23. Causes of Coma

Structural (Focal)

• Massive hemispheric infarction or haemorrhage
• Brainstem infarction
• Subdural/extradural haematoma
• Brain tumour with herniation
• Traumatic brain injury

Metabolic / Diffuse (Non-focal)

---

24. Three Types of Epilepsy

1. Generalised Tonic-Clonic Seizures (Grand Mal) — sudden loss of consciousness, tonic phase (rigid stiffening) then clonic phase (rhythmic jerking); tongue bite, incontinence, post-ictal confusion; both hemispheres involved from onset
2. Absence Seizures (Petit Mal) — brief (5–30 sec) sudden staring episodes with cessation of activity; no post-ictal state; 3 Hz spike-and-wave on EEG; common in children (childhood absence epilepsy)
3. Focal (Partial) Seizures — arise from one hemisphere/region; simple (preserved consciousness) or complex (impaired consciousness); can secondarily generalise; may have aura; temporal lobe is most common origin

---

25. Three Common Causes of Seizures in Elderly

1. Stroke / Cerebrovascular disease — most common cause of new-onset seizures in elderly; cortical infarcts or haemorrhages act as epileptic foci; both acute symptomatic (within 1 week of stroke) and remote symptomatic (post-stroke epilepsy)
2. Brain tumours — primary (glioblastoma) or metastatic; cortical irritation from tumour mass or surrounding oedema; seizure may be presenting feature of an occult tumour
3. Metabolic disturbances — hyponatraemia, hypoglycaemia, hypocalcaemia, uraemia, hepatic encephalopathy, alcohol withdrawal; all lower seizure threshold in elderly who have less physiological reserve

---

26. Three Perceptual Disorders

1. Agnosia — inability to recognise objects, people, sounds, or shapes despite intact sensory function and intelligence. Types include:
   • Visual agnosia: Cannot recognise objects by sight (but can by touch)
   • Prosopagnosia: Cannot recognise familiar faces
   • Astereognosis: Cannot recognise objects by touch
   • Caused by association cortex lesions (occipital, parietal, temporal)
2. Apraxia — inability to perform learned, purposeful motor tasks despite intact motor function, sensory function, and comprehension. Types include:
   • Ideomotor apraxia: Cannot mimic gestures (e.g., wave goodbye) on command
   • Constructional apraxia: Cannot copy drawings (e.g., clock face, cube)
   • Dressing apraxia: Cannot dress correctly
   • Caused by dominant parietal lobe lesions
3. Neglect (Hemi-inattention) — failure to attend to stimuli on one side of the body or space, without primary sensory or motor loss. Types:
   • Sensory neglect: Ignores sensory stimuli from contralateral side
   • Motor neglect: Fails to use contralateral limb spontaneously
   • Spatial neglect: Ignores one side of space (e.g., only eats from one side of plate)
   • Caused by right parietal lobe lesions (left-sided neglect most common)

---

27. Three Drugs Used in Generalised Seizures

1. Sodium Valproate (Valproic acid) — broad-spectrum antiepileptic; first-line for generalised seizures including tonic-clonic and absence; mechanism: enhances GABA, blocks sodium channels; avoid in women of childbearing age (teratogenic)
2. Lamotrigine — effective for generalised tonic-clonic and absence seizures; sodium channel blocker; first-line alternative especially in women; slow titration required to avoid Stevens-Johnson syndrome
3. Levetiracetam — broad-spectrum; binds SV2A (synaptic vesicle protein); effective for generalised seizures; IV form available for status epilepticus; well tolerated; may cause behavioural side effects

---

28. Three Classical Signs of Parkinson's Disease

1. Tremor — resting tremor; "pill-rolling" character (4–6 Hz); present at rest, diminishes with intentional movement; begins unilaterally; hands > legs > jaw
2. Rigidity — increased muscle tone throughout range of movement ("lead-pipe"); "cogwheeling" when combined with tremor; tested by passive limb movement
3. Bradykinesia — slowness of movement; hypokinesia (reduced amplitude); difficulty initiating movement; micrographia (small handwriting); hypomimia (mask-like face); shuffling gait; loss of arm swing

Postural instability is the fourth cardinal sign (TRAP).

---

29. Three Drugs Used in Parkinson's Disease

1. Levodopa + Carbidopa (Co-careldopa / Sinemet) — gold standard; levodopa is dopamine precursor that crosses BBB; carbidopa is peripheral dopa-decarboxylase inhibitor (prevents peripheral conversion, reduces side effects); most effective symptomatic treatment; long-term complications: motor fluctuations ("on-off"), dyskinesias
2. Dopamine Agonists (Pramipexole, Ropinirole, Rotigotine) — directly stimulate dopamine receptors; used as monotherapy in early disease or adjunct to levodopa; lower risk of dyskinesias; side effects: impulse control disorders, hallucinations, orthostatic hypotension
3. MAO-B Inhibitors (Selegiline, Rasagiline) — inhibit monoamine oxidase B → prevent dopamine breakdown; used in early disease or as adjunct; neuroprotective properties debated; well tolerated

---

30. Describe and Define Chorea

• Movements are brief (< 1 second), purposeless, and random
• Appear to flow from one muscle group to another
• Patient may attempt to incorporate them into semi-purposeful gestures ("parakinesia")
• Often associated with hypotonia
• Gait may be irregular and unsteady
• Movements increase with anxiety and decrease with sleep
• In severe cases, can impair speech (dysarthria), swallowing (dysphagia), and ambulation

• Huntington's disease (autosomal dominant, CAG repeat in HTT gene)
• Sydenham's chorea (post-streptococcal, rheumatic fever — especially children)
• Systemic lupus erythematosus (chorea gravidarum in pregnancy)
• Hyperthyroidism
• Drug-induced (levodopa, antipsychotics — tardive dyskinesia)
• Polycythaemia vera, Wilson's disease

---

31. Define Ballismus

• Typically unilateral (hemiballismus) — contralateral to lesion
• Most common cause: infarction of the subthalamic nucleus (STN) of the basal ganglia
• The STN normally inhibits the globus pallidus; its loss leads to disinhibited thalamic excitation of the motor cortex
• Other causes: hyperglycaemic state (non-ketotic hyperglycaemia), MS, tumour, HIV
• Can be severe enough to cause exhaustion and injury
• Treatment: dopamine-depleting agents (tetrabenazine), antipsychotics (haloperidol), or deep brain stimulation in refractory cases

---

32. Three Causes of Ataxia

1. Multiple Sclerosis — demyelinating plaques in the cerebellum or cerebellar connections; cerebellar ataxia is a common presenting or evolving feature; typically young adults
2. Spinocerebellar Ataxia (SCA) / Friedreich's Ataxia — Friedreich's ataxia: autosomal recessive, GAA repeat expansion in frataxin gene; onset in teens; progressive gait and limb ataxia, dysarthria, sensory loss, cardiomyopathy, diabetes
3. Cerebellar infarction or haemorrhage — sudden onset ataxia; posterior circulation stroke (PICA, AICA, SCA territory); presents with sudden vertigo, gait ataxia, headache, nausea; risk of brainstem compression

---

33. Ataxia Telangiectasia (AT)

Key Features

Diagnosis

• Elevated serum alpha-fetoprotein (AFP) — hallmark finding
• Low serum immunoglobulins (IgA, IgE)
• ATM gene mutation analysis
• Chromosomal instability on karyotype

Prognosis

• Most patients become wheelchair-bound by teenage years
• Death usually from recurrent chest infections or malignancy; life expectancy 25–50 years

---

34. Three Diseases Affecting the Posterior Column of the Spinal Cord

1. Subacute Combined Degeneration of the Cord (SCDC) — due to Vitamin B12 (cobalamin) deficiency; demyelination of posterior columns AND lateral corticospinal tracts; features: loss of vibration/proprioception, positive Romberg's sign, spastic paraparesis, peripheral neuropathy; causes: pernicious anaemia, veganism, gastrectomy
2. Tabes Dorsalis — tertiary neurosyphilis; inflammatory degeneration of posterior columns and dorsal nerve roots; features: lightning pains, loss of proprioception, sensory ataxia, Argyll Robertson pupils, Charcot joints, loss of deep tendon reflexes
3. Friedreich's Ataxia — spinocerebellar degeneration affecting posterior columns and spinocerebellar tracts; loss of proprioception and vibration, sensory ataxia, absent ankle reflexes, pes cavus, scoliosis, cardiomyopathy

---

35. Types of Multiple Sclerosis

---

36. Three Clinical Features of Multiple Sclerosis

1. Optic Neuritis — unilateral painful loss of vision; reduced colour vision (especially red desaturation); afferent pupillary defect (Marcus Gunn pupil); most common presenting feature in young women; typically recovers but leaves Uhthoff's phenomenon (worsening with heat)
2. Internuclear Ophthalmoplegia (INO) — bilateral INO in a young adult is virtually pathognomonic of MS; due to demyelination of the MLF in the pons; impaired adduction ipsilateral to lesion with abducting nystagmus
3. Spastic Paraparesis — progressive bilateral leg weakness with spasticity, hyperreflexia, Babinski signs; from demyelinating plaques in the corticospinal tracts of the spinal cord; associated with bladder dysfunction (urgency, incontinence)

---

37. Three Clinical Features of Axillary Nerve Palsy

1. Weakness of shoulder abduction — deltoid weakness; inability to abduct the arm from 0–90° (initial 15° of abduction by supraspinatus is preserved); patient cannot raise arm to the side
2. Wasting of the deltoid muscle — visible and palpable flattening of the shoulder contour; loss of the normal rounded shoulder appearance
3. Sensory loss over the "regimental badge" area — patch of numbness over the upper outer arm/deltoid region; supplied by the superior lateral cutaneous nerve of the arm (branch of axillary nerve)

---

38. Three Causes of Wasting of Small Muscles of the Hand

1. Ulnar nerve palsy — wasting of hypothenar muscles, interossei, and medial two lumbricals; "claw hand" deformity (ring and little fingers); causes: cubital tunnel syndrome, elbow fracture, leprosy
2. Motor Neuron Disease (Amyotrophic Lateral Sclerosis) — combination of UMN and LMN signs; wasting and fasciculations in hand muscles with hyperreflexia elsewhere; progressive and bilateral; no sensory loss
3. Cervical spondylotic myelopathy / C8–T1 radiculopathy — compression of C8 or T1 nerve roots by cervical disc prolapse or osteophytes; wasting of intrinsic hand muscles with sensory changes in medial forearm and hand

---

39. Three Symptoms of Radial Nerve Palsy

1. Wrist drop — inability to extend the wrist; most characteristic sign; radial nerve supplies all wrist extensors (extensor carpi radialis longus, brevis, extensor carpi ulnaris); the wrist hangs in flexion
2. Finger drop — inability to extend the fingers at the metacarpophalangeal joints; loss of extensor digitorum function; grip is also weakened (inability to stabilise wrist in extension)
3. Sensory loss over the dorsum of the hand — anaesthesia/paraesthesia on the dorsal (posterior) surface of the hand, particularly over the first dorsal web space; supplied by the superficial radial nerve

---

40. Three Complications of Diabetic Autonomic Neuropathy

1. Gastroparesis — vagal denervation of the stomach causes delayed gastric emptying; presents with early satiety, nausea, vomiting, bloating, postprandial fullness; can lead to unpredictable glycaemic control; diagnosed with gastric emptying scintigraphy
2. Cardiovascular Autonomic Neuropathy (CAN) — resting tachycardia, reduced heart rate variability, orthostatic hypotension, silent myocardial ischaemia; associated with 2–5-fold increased mortality; risk of sudden cardiac death
3. Erectile Dysfunction / Genitourinary Dysfunction — affects 30–75% of diabetic males; neurogenic erectile dysfunction (parasympathetic denervation); also neurogenic bladder (incomplete emptying, overflow incontinence, recurrent UTIs) and retrograde ejaculation

---

41. Three Clinical Features of Brain Tumours

1. Raised Intracranial Pressure (ICP) — headache (worse in the morning, on bending/coughing/sneezing), nausea and vomiting, papilloedema on fundoscopy, visual obscurations; caused by tumour bulk, cerebral oedema, or hydrocephalus
2. Focal neurological deficits — dependent on tumour location: hemiparesis (motor cortex), aphasia (dominant frontal/temporal), visual field defects (occipital/temporal), ataxia (cerebellum), personality change (frontal lobe), memory loss (temporal lobe)
3. Seizures — new-onset seizures in adults always warrant investigation; cortical irritation by tumour; can be focal or generalised; often the presenting feature of slow-growing tumours (e.g., low-grade glioma, meningioma)

---

42. Three Motor Neuron Diseases + Note on Neuromyotonia

Three Motor Neuron Diseases

1. Amyotrophic Lateral Sclerosis (ALS) — most common MND; affects both UMN and LMN; progressive limb weakness, wasting, fasciculations with hyperreflexia and Babinski; spares cognition and eye movements until late; fatal within 3–5 years (respiratory failure)
2. Progressive Muscular Atrophy (PMA) — LMN only; progressive wasting and weakness without upper motor neuron signs; presents with hand and limb wasting; slower progression than ALS
3. Primary Lateral Sclerosis (PLS) — UMN only; progressive spastic paraparesis with hyperreflexia and Babinski; no wasting or fasciculations; slowest progression; better prognosis

Neuromyotonia (Isaacs' Syndrome)

• Continuous muscle fibre activity — spontaneous, irregular muscle contractions even at rest
• Myokymia — rippling or undulating movements visible under the skin
• Cramps, stiffness, hyperhidrosis (excessive sweating)
• Pseudomyotonia — delayed relaxation of grip (but unlike true myotonia, not worsened by cold)
• Cause: Autoantibodies against voltage-gated potassium channels (VGKC/CASPR2) → reduced K+ channel function → prolonged axonal depolarisation
• Associated with thymoma, lung cancer, or autoimmune conditions
• Treatment: Carbamazepine or phenytoin (membrane stabilisers); immunotherapy (plasma exchange, IVIG, steroids)

---

43. Myasthenia Gravis — Etiology and Pathophysiology

Etiology

• Autoimmune disorder — most common cause of defective neuromuscular transmission
• Anti-acetylcholine receptor (AChR) antibodies — present in ~85% of generalised MG; IgG antibodies
• Anti-MuSK antibodies — present in ~5–10% of AChR-antibody negative patients; muscle-specific kinase
• Anti-LRP4 antibodies — rare; another postsynaptic target
• Associated with thymoma (15%) and thymic hyperplasia (65%) — thymus plays a key role in generating autoreactive T cells
• Associations: Other autoimmune diseases (rheumatoid arthritis, SLE, thyroid disease)

Pathophysiology

1. Autoreactive CD4+ T cells (sensitised in the thymus) stimulate B cells to produce IgG anti-AChR antibodies
2. These antibodies:
   • Block the AChR directly (competitive inhibition of ACh binding)
   • Accelerate degradation of AChRs (cross-linking and internalisation)
   • Activate complement → destruction of postsynaptic membrane (simplification of junctional folds)
3. Reduced functional AChRs → reduced end-plate potential → reduced chance of generating muscle action potential
4. Fatigable weakness: With repeated activity, ACh release decreases (normal phenomenon) but now insufficient to overcome reduced AChRs → progressive weakness with use, recovery with rest

Clinical Features

• Fatigable, painless weakness — hallmark
• Ocular: Ptosis, diplopia — most common presenting feature
• Bulbar: Dysarthria, dysphagia, dysphonia — worsen through the day
• Limb weakness: Proximal > distal; arms > legs
• Respiratory crisis (myasthenic crisis) — life-threatening respiratory failure; triggers: infection, surgery, drugs (aminoglycosides, beta-blockers)
• Symptoms worse toward evening, better after sleep

---

44. Clinical Features of Radial Nerve Palsy

• Wrist drop (cannot extend wrist)
• Finger drop (cannot extend fingers at MCP joints)
• Weakened grip (secondary to inability to stabilise wrist)
• Sensory loss: dorsum of hand and first dorsal web space
• Preserved: elbow extension (triceps), elbow flexion (brachioradialis weak but present), triceps jerk

---

45. Encephalitis

Causes

Clinical Features

• Fever + headache (as in meningitis)
• Altered consciousness — confusion, drowsiness, behavioural change
• Seizures — focal or generalised
• Focal neurological deficits — aphasia, hemiparesis
• HSV encephalitis specifically: temporal lobe involvement → personality change, memory loss, olfactory hallucinations, temporal lobe seizures

Diagnosis

• MRI brain — temporal lobe signal change (T2/FLAIR hyperintensity) in HSV encephalitis
• CSF analysis: Lymphocytic pleocytosis, elevated protein, normal/mildly low glucose
• CSF PCR for HSV — gold standard diagnosis
• EEG: Temporal lobe discharges; periodic lateralised epileptiform discharges (PLEDs)

Treatment

• HSV encephalitis: IV Aciclovir 10 mg/kg 8-hourly for 14–21 days (start empirically without waiting for results)
• Autoimmune encephalitis: High-dose steroids, IVIG, plasma exchange; rituximab/cyclophosphamide for refractory cases
• Seizure management, supportive ICU care

---

46. Transverse Myelitis

Causes

• Idiopathic (most common)
• Multiple sclerosis (partial/incomplete transverse myelitis, typically unilateral)
• Neuromyelitis Optica Spectrum Disorder (NMOSD) — anti-AQP4 antibodies; longitudinally extensive transverse myelitis (LETM — ≥3 vertebral segments)
• Post-infectious / Para-infectious (VZV, EBV, Mycoplasma, COVID-19)
• Autoimmune: SLE, Sjogren's syndrome
• Sarcoidosis

Clinical Features (Triad)

1. Motor: Bilateral limb weakness (paraplegia or tetraplegia depending on level); initially flaccid (spinal shock), then spastic
2. Sensory: Sensory level — a band-like sensation at the level of the lesion; loss of all sensory modalities below the level
3. Autonomic: Bladder (urinary retention → overflow incontinence), bowel dysfunction, sexual dysfunction; autonomic dysreflexia in high lesions

Diagnosis

• MRI spine: Gadolinium-enhancing lesion(s) in the cord; LETM (>3 segments) suggests NMOSD
• CSF: Inflammatory pleocytosis, elevated protein
• AQP4-IgG antibody (NMO-IgG) — test for NMOSD
• Anti-MOG antibodies — MOG-associated disease

Treatment

• Acute: High-dose IV methylprednisolone (1g/day × 3–5 days)
• Severe/refractory: Plasma exchange
• NMOSD: Long-term immunosuppression (azathioprine, mycophenolate, rituximab)
• Rehabilitation, bladder/bowel management

---

47. Cerebral Palsy — Definition and Types

CP itself is non-progressive but its clinical manifestations may change over time.

Causes

• Hypoxic-ischaemic encephalopathy (perinatal asphyxia)
• Prematurity and periventricular leukomalacia
• Intrauterine infection (TORCH)
• Metabolic (kernicterus — bilirubin encephalopathy)
• Stroke, trauma

Types of Cerebral Palsy

---

48. Three Clinical Features of Muscular Dystrophy

1. Progressive proximal muscle weakness — difficulty rising from the floor, climbing stairs, raising arms above head; typically presents in boys aged 3–5 years; Gowers' sign: child uses arms to "walk up" legs to stand from the floor due to proximal lower limb weakness
2. Pseudohypertrophy of calves — enlarged but weak calf muscles; due to replacement of muscle fibres with fat and connective tissue; pathognomonic appearance
3. Cardiac and respiratory involvement — dilated cardiomyopathy (invariable by late teens); respiratory failure from diaphragmatic weakness; commonest cause of death; ECG shows tall R waves in V1 and deep Q waves in lateral leads

---

49. Hydrocephalus — Definition and Types

Types

---

50. Three Complications of Craniotomy

1. Intracranial haemorrhage — extradural, subdural, or intracerebral haematoma; may occur during or after surgery; presents with deteriorating consciousness, new focal deficits; requires urgent re-exploration
2. Brain oedema and raised ICP — post-operative cerebral swelling; managed with head elevation, osmotic agents (mannitol, hypertonic saline), corticosteroids (for vasogenic oedema around tumours), and sometimes decompressive measures
3. Infection — meningitis, cerebral abscess, wound infection, osteomyelitis of bone flap; risk of subdural empyema; treated with prolonged IV antibiotics; infected bone flap may require removal

---

51. Three Indications for Craniotomy

1. Intracranial space-occupying lesion — surgical resection of brain tumours (primary glioma, meningioma, metastases); craniotomy allows tumour debulking, biopsy, or complete excision
2. Intracranial haemorrhage — evacuation of large intracerebral haematoma, subdural empyema, or chronic subdural haematoma causing significant mass effect or neurological deterioration
3. Aneurysm clipping / AVM resection — surgical treatment of cerebral aneurysm (clip placed at aneurysm neck to prevent re-bleeding in SAH) or arteriovenous malformation excision

---

52. Three Complications of Shunting

1. Shunt obstruction/blockage — most common complication; proximal (ventricular catheter tip blocked by choroid plexus) or distal obstruction; presents with return of raised ICP symptoms; requires shunt revision
2. Shunt infection — Staphylococcus epidermidis most common organism; presents with fever, meningism, peritonitis (ventriculoperitoneal shunt); treated with IV antibiotics + shunt externalisation or replacement
3. Over-drainage — excessive CSF drainage → low-pressure headache (worse upright), subdural haematoma/hygroma from bridging vein tearing; managed with programmable valve adjustment

---

53. Three Complications of Laminectomy

1. Epidural haematoma — bleeding into the epidural space post-operatively; can compress the spinal cord or cauda equina; presents with sudden back pain and progressive neurological deficit; requires emergency re-exploration and haematoma evacuation
2. Infection — wound infection, epidural abscess, discitis, osteomyelitis; presents with wound erythema, fever, back pain; treated with antibiotics; abscess requires surgical drainage
3. Neurological deficit / Dural tear — inadvertent CSF leak from dural tear during surgery causes positional headache (post-dural puncture headache); nerve root injury during dissection can cause radiculopathy or permanent neurological deficit; CSF fistula may require re-exploration

---

54. Complications of Stereotactic Surgery

---

55. What is Shunting?

Types of Shunts

Components of a Shunt

• Ventricular catheter (proximal) — placed in lateral ventricle
• Valve — one-way pressure-regulated valve to prevent over/under-drainage
• Distal catheter — tunnelled subcutaneously to the destination cavity

Programmable Valves

• Pressure settings can be adjusted non-invasively using a magnet
• Allows fine-tuning to prevent over- or under-drainage

---

56. Three Indications for Shunting

1. Obstructive hydrocephalus — blockage of CSF flow within the ventricular system (e.g., aqueduct stenosis, posterior fossa tumour); shunting bypasses the obstruction and prevents raised ICP
2. Communicating hydrocephalus — impaired CSF reabsorption (post-meningitic, post-haemorrhagic, congenital); shunting provides an alternative drainage route
3. Normal Pressure Hydrocephalus (NPH) — classic triad of gait apraxia, dementia, and urinary incontinence; LP trial showing gait improvement confirms shunt responsiveness; VP shunting improves or reverses the triad in suitable patients

---

Quick Index

• ✅ CN V (Trigeminal) examination
• ✅ CN VII (Facial) assessment
• ✅ Visual acuity and visual field tests
• ✅ Glasgow Coma Scale
• ✅ Three higher mental functions

• ✅ Three uses of lumbar puncture
• ✅ Three complications of lumbar puncture

• ✅ Internuclear ophthalmoplegia
• ✅ Three causes of ptosis
• ✅ Three causes of papilloedema

• ✅ Three differences UMN vs LMN
• ✅ Three causes of Bell's palsy
• ✅ Trigeminal neuralgia
• ✅ Dysphagia

• ✅ Three symptoms of ischaemic stroke
• ✅ Autonomic dysreflexia
• ✅ Risk factors of stroke
• ✅ Three causes of stroke in young
• ✅ Define CVA
• ✅ Three complications of head injury
• ✅ Postural hypotension

• ✅ Three causes of dementia (mentioned twice in your list — answered)
• ✅ Causes of coma
• ✅ Three perceptual disorders

• ✅ Three types of epilepsy
• ✅ Three causes of seizures in elderly
• ✅ Three drugs for generalised seizures

• ✅ Three classical signs of Parkinson's (mentioned twice — answered)
• ✅ Three drugs for Parkinson's (mentioned twice — answered)

• ✅ Describe Chorea
• ✅ Define Chorea
• ✅ Define Ballismus
• ✅ Three causes of ataxia
• ✅ Ataxia Telangiectasia

• ✅ Three diseases of posterior column
• ✅ Types of multiple sclerosis
• ✅ Three features of multiple sclerosis
• ✅ Transverse myelitis

• ✅ Three features of axillary nerve palsy
• ✅ Three causes of small muscle wasting
• ✅ Three symptoms of radial nerve palsy
• ✅ Clinical features of radial nerve palsy
• ✅ Three complications of diabetic autonomic neuropathy

• ✅ Three features of brain tumours
• ✅ Three motor neuron diseases + neuromyotonia
• ✅ Myasthenia gravis — etiology & pathophysiology

• ✅ Encephalitis

• ✅ Cerebral palsy — definition and types
• ✅ Three features of muscular dystrophy
• ✅ Hydrocephalus — definition and types

• ✅ Three complications of craniotomy
• ✅ Three indications for craniotomy
• ✅ Three complications of shunting
• ✅ Three complications of laminectomy
• ✅ Complications of stereotactic surgery
• ✅ What is shunting
• ✅ Three indications for shunting

---